VideaHealth Artificial Intelligence Dental Assist Receives FDA Clearance

VideaHealth's Dental Assist is now cleared by the United States Food and Drug Administration for the detection of dental diseases.

Dental artificial intelligence (AI) platform VideaHealth has achieved a groundbreaking milestone with the United States Food and Drug Administration (FDA) granting 510(k) clearance for their latest product, Videa Dental Assist. The clearance includes more than 30 AI algorithms, expanding AI detections to cover all of the most common dental diseases, according to a press release from VideaHealth.

Florian Hillen, CEO of VideaHealth, expressed the significance of this FDA clearance, stating in the press release, "This is one of the largest, most impactful FDA clearances in the history of health care and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients."

These new clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages 3 years and older, among many other AI models. These models are said to allow for detections across all ages, improving workflow and time-savings for dental professionals. Notably, some of these detections mark the first of their kind to be issued by a regulatory agency anywhere in the world, including the first pediatric radiology AI clearance in dentistry.

Dr Tim Quirt, Senior Vice President of Clinical Operations at Heartland Dental, expressed excitement about VideaHealth's expanding scope of AI capabilities, saying in the press release, "It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand. We are proud to partner with VideaHealth in this fast-moving field because their vision, mission, and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint."

Already embraced by thousands of clinicians, per VideaHealth, VideaAI has become the dental AI tool of choice for many, used daily to provide the best possible care for millions of patients. With this recent FDA clearance, VideaHealth aims to solidify its position as the first dental AI company to offer insights for virtually every disease state.